Furthermore, the inhibition of PD-L1 and CTLA4 in CD155−/− mice resulted in strongly increased anti-tumour effects compared to those of PD-L1/CTLA4 blockade in WT mice [210]. The gene discussed is PVR; the disease is neoplasm.